US Stock MarketDetailed Quotes

CVKD Cadrenal Therapeutics

Watchlist
  • 0.386
  • -0.019-4.69%
Trading Apr 16 14:05 ET
6.18MMarket Cap-601P/E (TTM)

Cadrenal Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
7.63M
1.26M
17.46%1.14M
112.75%1.03M
2,363.18%4.2M
972.79K
482.35K
170.52K
Selling and administrative expenses
--3.55M
--902.11K
-1.95%898.05K
180.11%784.62K
531.94%964.73K
--915.9K
--280.11K
--152.66K
-General and administrative expense
--3.55M
--902.11K
-1.95%898.05K
180.11%784.62K
531.94%964.73K
--915.9K
--280.11K
--152.66K
Research and development costs
--4.08M
--361.13K
332.62%243.95K
19.15%240.96K
18,014.88%3.24M
--56.39K
--202.24K
--17.86K
Depreciation amortization depletion
--1.98K
--597
17.98%597
--597
--190
--506
--0
--0
-Depreciation and amortization
--1.98K
--597
17.98%597
--597
--190
--506
--0
--0
Operating profit
-7.63M
-1.26M
-17.46%-1.14M
-112.75%-1.03M
-2,363.18%-4.2M
-972.79K
-482.35K
-170.52K
Net non-operating interest income expense
231.99K
119.77K
431.59%106.15K
256.91%23.18K
-272.65%-17.1K
-32.01K
-14.77K
-4.59K
Non-operating interest income
--249.09K
--119.77K
3,538,066.67%106.15K
--23.18K
----
--3
--0
----
Non-operating interest expense
--17.1K
--0
--0
--0
272.65%17.1K
--32.01K
--14.77K
--4.59K
Other net income (expense)
-956.23K
0
-62,073.86%-956.23K
-21.31K
-5.02K
-1.54K
Gain on sale of security
---216.1K
--0
----
----
-13,950.39%-216.1K
---21.31K
---5.02K
---1.54K
Special income (charges)
---740.14K
--0
--0
--0
---740.14K
--0
--0
--0
-Less:Other special charges
--740.14K
--0
----
----
--740.14K
----
----
----
Income before tax
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
-176.65K
Income tax
Net income
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
-176.65K
Net income continuous Operations
---8.36M
---1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
---1.03M
---502.14K
---176.65K
Minority interest income
Net income attributable to the parent company
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
-176.65K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-8.36M
-1.14M
-1.01%-1.04M
-99.74%-1M
-2,828.75%-5.17M
-1.03M
-502.14K
-176.65K
Basic earnings per share
-0.62
-0.05
20.63%-0.07
-108.53%-0.09
-3,061.43%-0.48
-0.0882
-0.0432
-0.0152
Diluted earnings per share
-0.62
-0.05
20.63%-0.07
-108.53%-0.09
-3,061.43%-0.48
-0.0882
-0.0432
-0.0152
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
Unqualified Opinion
--
--
--
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 00000000
Operating revenue --0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 7.63M1.26M17.46%1.14M112.75%1.03M2,363.18%4.2M972.79K482.35K170.52K
Selling and administrative expenses --3.55M--902.11K-1.95%898.05K180.11%784.62K531.94%964.73K--915.9K--280.11K--152.66K
-General and administrative expense --3.55M--902.11K-1.95%898.05K180.11%784.62K531.94%964.73K--915.9K--280.11K--152.66K
Research and development costs --4.08M--361.13K332.62%243.95K19.15%240.96K18,014.88%3.24M--56.39K--202.24K--17.86K
Depreciation amortization depletion --1.98K--59717.98%597--597--190--506--0--0
-Depreciation and amortization --1.98K--59717.98%597--597--190--506--0--0
Operating profit -7.63M-1.26M-17.46%-1.14M-112.75%-1.03M-2,363.18%-4.2M-972.79K-482.35K-170.52K
Net non-operating interest income expense 231.99K119.77K431.59%106.15K256.91%23.18K-272.65%-17.1K-32.01K-14.77K-4.59K
Non-operating interest income --249.09K--119.77K3,538,066.67%106.15K--23.18K------3--0----
Non-operating interest expense --17.1K--0--0--0272.65%17.1K--32.01K--14.77K--4.59K
Other net income (expense) -956.23K0-62,073.86%-956.23K-21.31K-5.02K-1.54K
Gain on sale of security ---216.1K--0---------13,950.39%-216.1K---21.31K---5.02K---1.54K
Special income (charges) ---740.14K--0--0--0---740.14K--0--0--0
-Less:Other special charges --740.14K--0----------740.14K------------
Income before tax -8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K-176.65K
Income tax
Net income -8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K-176.65K
Net income continuous Operations ---8.36M---1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M---1.03M---502.14K---176.65K
Minority interest income
Net income attributable to the parent company -8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K-176.65K
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -8.36M-1.14M-1.01%-1.04M-99.74%-1M-2,828.75%-5.17M-1.03M-502.14K-176.65K
Basic earnings per share -0.62-0.0520.63%-0.07-108.53%-0.09-3,061.43%-0.48-0.0882-0.0432-0.0152
Diluted earnings per share -0.62-0.0520.63%-0.07-108.53%-0.09-3,061.43%-0.48-0.0882-0.0432-0.0152
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg